Physician

Warren T Hitt, M.D.

According to 2025 Medicare claims, Warren Hitt, M.D. (NPI: 1356302897) practices urology in the Panama City-Panama City Beach, FL market, with the plurality of this provider's patient population coming from Bay, FL. This provider's primary affiliated billing organization is ADVANCED UROLOGY INSTITUTE, LLC (NPI: 1023447935; TIN: 46-2439971) and primary practice location at 32401-6304.

Hitt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,369 traditional Medicare patients, billed 41,478 HCPCS/CPT codes, and received $492,105 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,456 prescription claims across 506 beneficiaries totaling $1,851,022 in drug costs, led by Xtandi (Enzalutamide). 2023 DME data shows 30 claims. Open Payments data shows 56 records totaling $1,281. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $732,588 to $492,105. In contrast, Part D prescription costs have moved sharply higher in recent years, from $163,344 to $1,851,022. For DME billing, this smaller-volume category rose steadily, from $697 to $1,845.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,567	40,809	$732,588
2016	1,451	38,265	$740,858
2017	1,360	23,060	$613,668
2018	1,552	30,057	$694,033
2019	1,365	36,926	$569,420
2020	1,395	49,124	$581,354
2021	1,375	42,212	$451,328
2022	1,361	32,653	$462,956
2023	1,491	35,087	$454,712
2024	1,369	41,478	$492,105

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	388	1,263	$163,344
2016	387	1,321	$161,264
2017	364	1,153	$172,018
2018	357	1,215	$419,018
2019	419	1,309	$430,858
2020	419	1,325	$592,895
2021	393	1,070	$595,410
2022	385	1,053	$357,666
2023	480	1,283	$709,455
2024	506	1,456	$1,851,022

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	35	165	$10,704
2016	56	268	$16,512
2017	13	204	$15,857
2018	N/R	113	$16,738
2019	N/R	97	$17,719
2020	N/R	94	$16,123
2021	N/R	54	$10,428
2022	N/R	53	$15,298
2023	N/R	30	$3,569
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	547	935	$95
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	537	736	$68
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	720	1,156	$12
36415	Insertion of needle into vein for collection of blood sample	560	655	$7
81001	Manual urinalysis test with examination using microscope, automated	908	1,803	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	87	2,610	$1,239,066
Erleada	Apalutamide	30	900	$434,694
Myrbetriq	Mirabegron	71	5,386	$79,268
Orgovyx	Relugolix	14	420	$36,591
Gemtesa	Vibegron	26	1,760	$27,268

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	54	$1,281	Dendreon Pharmaceuticals LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	2	$14,921	SN Holdings, LLC

Explore More Providers

FAQ

What Medicare data is available for Warren T. Hitt, M.D.?

Tedicare shows public-source Medicare data for Warren T. Hitt, M.D. (NPI 1356302897), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Warren T. Hitt, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Warren T. Hitt, M.D.?

Warren T. Hitt, M.D. is linked to ADVANCED UROLOGY INSTITUTE, LLC (billing NPI 1023447935) in the available physician profile data.

Does Warren T. Hitt, M.D. have Open Payments data?

Warren T. Hitt, M.D. has 56 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.